https://www.pharmanow.live/latest-news/par-health-recalls-22-lots-argatroban-injection-particulate-matter 2026-10-14T22:07:44+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 Par Health Recalls 22 Lots of Argatroban Injection After Multi-Material Particulate Contamination Found Par Health https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fb59f8b0-06cc-4170-85bf-a14c29535466/a48675d1-e530-4980-be85-3aaa635cbad1.png https://www.pharmanow.live/latest-news/fda-cber-finalizes-blood-donation-suitability-source-plasma-quarantine-hold-compliance-policy 2026-10-14T22:09:15+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FDA CBER Finalizes Compliance Policy on Blood Donation Suitability and Source Plasma Quarantine Hold Requirements FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fb59f8b0-06cc-4170-85bf-a14c29535466/c8152098-6dab-4ca5-8363-51e709c0b4d5.png https://www.pharmanow.live/latest-news/fda-rare-disease-framework-initiative-risk-based-cmc-review-pre-approval-inspection 2026-10-14T22:10:09+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FDA Launches Rare Disease Framework Initiative Targeting Risk-Based CMC Review and Pre-Approval Inspection Reform FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fb59f8b0-06cc-4170-85bf-a14c29535466/7336fb3f-2c57-4e58-be5e-3c3c272ee7c6.png https://www.pharmanow.live/latest-news/hepion-pharmaceuticals-acquires-gravitas-life-sciences-gv104-manufacturing 2026-10-14T22:16:09+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 Hepion Pharmaceuticals Acquires Gravitas Life Sciences Hepion Acquires https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://app.accessnewswire.com/img.ashx?id=1236645 https://www.pharmanow.live/latest-news/fibrobiologics-australian-patent-acceptance-fibroblast-spinal-disc-regeneration 2026-10-14T22:11:42+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FibroBiologics Secures Australian Patent Acceptance for Fibroblast-Based Spinal Disc Regeneration Method FibroBiologics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fb59f8b0-06cc-4170-85bf-a14c29535466/2e91337c-4836-493e-abff-dfd551b3bade.png https://www.pharmanow.live/latest-news/fda-compliance-policy-blood-pressure-pulse-donor-eligibility-blood-establishments 2026-10-14T22:18:16+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 FDA Issues Compliance Policy on Blood Pressure and Pulse Donor Eligibility for Blood Establishments FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fb59f8b0-06cc-4170-85bf-a14c29535466/3403e018-70bf-40ca-aa27-783c6e94a48d.png https://www.pharmanow.live/latest-news/atara-biotherapeutics-fda-accepts-tabelecleucel-bla-resubmission-march-2027-pdufa 2026-10-14T22:12:57+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 Atara Biotherapeutics Gains FDA Acceptance of Tabelecleucel Atara https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fb59f8b0-06cc-4170-85bf-a14c29535466/1b409257-8ff8-4efb-86d4-ebaa4109b843.png https://www.pharmanow.live/latest-news/immunitybio-fda-expanded-approval-anktiva-high-grade-papillary-nmibc 2026-10-14T22:14:48+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 ImmunityBio Gains FDA Expanded Approval for Anktiva in High-Grade Papillary BCG-Unresponsive NMIBC FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/fb59f8b0-06cc-4170-85bf-a14c29535466/97306eff-f63b-45c4-983a-5494ec043593.png https://www.pharmanow.live/latest-news/roche-rona-therapeutics-1-16-billion-obesity-deal 2026-10-14T22:07:00+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 Roche Signs $1.16 Billion Deal with Rona Therapeutics for Fat-Tissue Obesity Program Roche https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/8e948179-13e0-40e3-8451-2e0a94021df7/9c2b5134-7ecc-4cf6-a59e-41870598b279.png https://www.pharmanow.live/latest-news/sanner-group-coo-frank-bamberg 2026-10-14T12:04:01+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Sanner Group COO Frank Bamberg Appointed to Lead Operations Sanner Group COO https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sanner-group-coo-frank-bamberg20261014120301.webp https://www.pharmanow.live/latest-news/cervavac-who-prequalification-serum-institute 2026-10-14T11:50:48+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 CERVAVAC WHO Prequalification Secured by Serum Institute CERVAVAC WHO prequalification https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cervavac-who-prequalification-hpv-vaccine20261014115040.webp https://www.pharmanow.live/latest-news/bix-2026-counts-down-to-opening-with-post-glp-1-session-on-the-next-obesity-treatment-market 2026-10-14T10:45:02+05:30 Pharma Now en 2026-10-14T00:00:00+05:30 BIX 2026 Counts Down to Opening with Post-GLP-1 Session on the Next Obesity Treatment Market BIX 2026, BIOPLUS INTERPHEX KOREA 2026, Post-GLP-1 obesity market, next-generation obesity treatments, BIX 2026 conference schedule https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/BIX2026Photo20261014104350.png https://www.pharmanow.live/latest-news/eurofins-sf-analytical-laboratories-fda-warning-letter-microbial-data-integrity-2026 2026-10-14T11:37:15+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Eurofins SF Analytical Laboratories FDA Warning Letter Issued Eurofins SF Analytical Laboratories FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/eurofins-sf-analytical-laboratories-fda-warning-letter20261014113516.webp https://www.pharmanow.live/latest-news/lovelace-biomedical-fda-warning-letter-glp-raw-data-reconciliation-2026 2026-10-14T11:31:03+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Lovelace Biomedical FDA Warning Letter Cites GLP Data Failures Lovelace Biomedical FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lovelace-biomedical-fda-warning-letter20261014112901.webp https://www.pharmanow.live/latest-news/hanlim-pharm-fda-warning-letter-aseptic-failures-sterile-fill-finish-2026 2026-10-14T11:24:50+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Hanlim Pharm FDA Warning Letter Cites Aseptic Failures Hanlim Pharm FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/hanlim-pharm-fda-warning-letter20261014112229.webp https://www.pharmanow.live/latest-news/sca-pharmaceuticals-fda-warning-letter-503b-sterile-compounding-cgmp-2026 2026-10-14T11:17:28+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 SCA Pharmaceuticals Receives FDA Warning Letter Over CGMP Gaps SCA Pharmaceuticals receives FDA warning letter https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/sca-pharmaceuticals-fda-warning-letter-503b-cgmp-failures-202620261014111724.webp https://www.pharmanow.live/latest-news/bristol-myers-squibb-ryz101-phase-3-primary-endpoint-neuroendocrine-cancer 2026-10-14T11:04:24+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Bristol Myers Squibb’s RYZ101 Meets Phase 3 Endpoint in GEP-NETs Bristol Myers Squibb’s RYZ101, BMS RYZ101 https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/bms-ryz101-phase-3-endpoint-neuroendocrine-cancer-202620261014110417.webp https://www.pharmanow.live/latest-news/phio-pharmaceuticals-completes-first-commercial-scale-cgmp-batch-ph-762 2026-10-14T11:00:01+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Phio Pharmaceuticals Completes PH-762 Commercial-Scale Batch Phio Pharmaceuticals https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/phio-pharmaceuticals-commercial-scale-cgmp-batch-ph-762-202620261014105843.webp https://www.pharmanow.live/latest-news/lonza-qurient-exclusive-deal-dual-payload-adc-cancer-therapies 2026-10-14T10:55:18+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Lonza-Qurient Deal Expands Dual-Payload ADC Technology Lonza-Qurient https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/lonza-qurient-dual-payload-adc-cancer-therapies-202620261014105508.webp https://www.pharmanow.live/latest-news/perceptive-discovery-nucleus-radiopharma-partnership-radiopharmaceutical-development 2026-10-14T10:48:56+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Perceptive Discovery Partners With Nucleus RadioPharma Perceptive Discovery https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/perceptive-discovery-nucleus-radiopharma-partnership-radiopharmaceutical-development-202620261014104606.webp https://www.pharmanow.live/latest-news/zydus-formycon-fda-accepts-first-pembrolizumab-biosimilar-bla-review 2026-10-14T10:40:49+05:30 Pharma Now en 2026-10-13T00:00:00+05:30 Zydus & Formycon Secure FDA Review for Pembrolizumab Biosimilar Zydus & Formycon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/zydus-formycon-fda-accepts-first-pembrolizumab-biosimilar-bla-review-202620261014103722.webp https://www.pharmanow.live/latest-news/dr-reddys-fto-11-andhra-pradesh-fda-form-483-observations 2026-10-13T11:26:29+05:30 Pharma Now en 2026-10-12T00:00:00+05:30 Dr. Reddy's FTO-11 Plant Receives Two FDA Form 483 Observations After Andhra Pradesh Inspection Dr. Reddy's https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/dr-reddys-fto-11-andhra-pradesh-fda-form-483-observations-202620261013112445.webp https://www.pharmanow.live/latest-news/cadila-pharmaceuticals-appoints-nirav-gandhi-president 2026-10-13T11:15:53+05:30 Pharma Now en 2026-10-12T00:00:00+05:30 Cadila Pharmaceuticals Appoints Nirav Gandhi as President Amid US Market Push Cadila https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/cadila-pharmaceuticals-nirav-gandhi-president-202620261013111539.webp